By the Numbers

Improved relative value in lower-coupon MBS

| March 1, 2024

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

Lower-coupon agency MBS underperformed last week after Truist Financial Corp. announced plans to restructure its available-for-sale portfolio. The bank seems likely to sell lower-coupon Fannie Mae and Freddie Mac MBS, possibly replacing them with production-coupon Ginnie Mae MBS. The underperformance improved relative value in these lower coupons. Investors that own Freddie Mac CMBS, for example, can add as much as 75 bp to projected base case 1-year total returns by shifting into agency specified pools or TBA. Investors would also pick up better liquidity and, if invested in TBA, the possibility of special financing in the dollar roll market.

Strongest projected performance in specified pools

Projected 1-year total returns on 30-year pools backed by loans with low loan balances come in as much as 75 bp higher than a blend of Freddie Mac K Deal CMBS (Exhibit 1). Returns on loan-balance pools with a 3.0%, 3.5% or 4.0% coupon all top projected returns on a duration-matched blend of Freddie Mac K securities. Each MBS represents a pool that contains loans with original loan size of at most $225,000. The CMBS comparison is combination of 5- and 10-year Freddie K securities. An appendix to this note shows projection details. The return advantage is strongest with no or only modest moves in rates and then declines with bigger moves, reflecting the greater negative convexity of the pools. But the specified pools still outperform in parallel shift rate scenarios that range from 100 bp lower to 100 bp higher.

Exhibit 1: FNCL 3% to 4% Max $225k pools top projected TRR on Freddie Ks.

Projected 1-year excess returns of FNCL specified pools vs. a proceeds- and duration-neutral portfolio of Freddie Mac K bonds. The specified pools contain loans with no more than $225,000 original loan balance. Details are in the appendix. All market levels as of 27 Feb 2024 close from BVAL. Investors in specified pools generally cannot take advantage of special dollar roll financing.
Source: Yield Book, Santander US Capital Markets

TBA also outperforms and adds liquidity and possible special financing

Some investors prefer the liquidity of the agency TBA market. TBAs also outperform proceeds- and duration-neutral portfolios of Freddie Ks, although not by as much as the specified pools (Exhibit 2). For example, the 3.0%s and 3.5%s peak at close to 50 bp projected excess return over the corresponding CMBS portfolios, while the FNCL 4.0% reaches 61 bp excess return. The TBA also have more negative convexities, which causes excess returns to fall more in large rate moves. The TBAs are projected to underperform if rates increase more than 75 bp but are projected to outperform in the other scenarios. But these projected return miss an important attribute of TBA: the possibility of special financing.

Exhibit 2. FNCL 3% to 4% TBA pools show lower, more limited excess TRR.

Projected 1-year excess returns of FNCL TBA vs. a proceeds- and duration-neutral portfolio of Freddie Mac K bonds. Details are in the appendix. All market levels as of 27 Feb 2024 close from BVAL. Total returns do not include the potential for special dollar rolls.
Source: Yield Book, Santander US Capital Markets

One benefit to investing in TBA is access to special financing provided by the dollar roll market. Occasionally demand for MBS is high and investors can earn a higher rate of return from rolling positions than they can from holding pools and earning the carry. The total returns projected here do not account for the possibility of special financing. Investors in specified pools will typically not dollar roll those positions since the investor’s pool would likely be replaced with a different pool with lower convexity.

It is likely that most of the bonds Truist sells will be in the 2.0% and 2.5% coupons produced en masse during the Covid refinance wave. Banks were heavy buyers of those securities.  Option-adjusted spreads on coupons as high as 4.5%s jumped wider after the Truist announcement. However, the 3.0% and higher coupons may be less likely to face more spread widening when the sales commence.

Details of all securities and return projections are in the appendix.

APPENDIX

Exhibit 3. FNCL 3.0% 2020 Max $225k vs 5Y and 10Y Freddie Ks.

All market levels as of 27 Feb 2024 close. Indicative prices from BVAL. Specified pools do not benefit from special dollar rolls.
Source: Yield Book, Santander US Capital Markets

Exhibit 4. FNCL 3.5% 2020 Max $225k vs 5Y and 10Y Freddie Ks.

All market levels as of 27 Feb 2024 close. Indicative prices from BVAL. Specified pools do not benefit from special dollar rolls.
Source: Yield Book, Santander US Capital Markets

Exhibit 5. FNCL 4.0% 2022 Max $225k vs 5Y and 10Y Freddie Ks.

All market levels as of 27 Feb 2024 close. Indicative prices from BVAL. Specified pools do not benefit from special dollar rolls.
Source: Yield Book, Santander US Capital Markets

Exhibit 6. FNCL 3.0% vs 5Y and 10Y Freddie Ks.

All market levels as of 27 Feb 2024 close. Indicative prices from BVAL. Total returns do not include potential for special dollar rolls.
Source: Yield Book, Santander US Capital Markets

Exhibit 7. FNCL 3.5% vs 5Y and 10Y Freddie Ks.

All market levels as of 27 Feb 2024 close. Indicative prices from BVAL. Total returns do not include potential for special dollar rolls.
Source: Yield Book, Santander US Capital Markets

Exhibit 8. FNCL 4.0% vs 5Y and 10Y Freddie Ks.

All market levels as of 27 Feb 2024 close. Indicative prices from BVAL. Total returns do not include potential for special dollar rolls.
Source: Yield Book, Santander US Capital Markets

Brian Landy, CFA
brian.landy@santander.us
1 (646) 776-7795

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

Important disclaimers for clients in the EU and UK

This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).

The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.

This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.

This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.

This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.

The Library

Search Articles